TACT

DRUG2 trials

Sponsors

University of Oxford

Conditions

Malaria, Falciparum

Phase 2

A Study by the Tracking Resistance to Artemisinin Collaboration (TRAC)

CompletedNCT02453308

University of OxfordMalaria, Falciparum

Start: 2015-08-31End: 2018-03-31Updated: 2018-05-09

Phase 3

Study to Compare the Triple ACT AL+AQ With the ACT AL in Cambodia and Vietnam

CompletedNCT03355664

University of OxfordMalaria, Falciparum

Start: 2018-03-19End: 2020-03-04Updated: 2022-07-15

Related Papers

Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.

2022-03-0855 citations

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.

2020-03-11189 citations

Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.

2019-07-22301 citations

The prevalence, incidence and prevention of Plasmodium falciparum infections in forest rangers in Bu Gia Map National Park, Binh Phuoc province, Vietnam: a pilot study.

2017-11-0610 citations